NON-CLINICAL SAFETY OF PTH-IA, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE.
Abstract
The objective of this study is to determine toxicity and toxicokinetics of PTH-IA
after BID daily subcutaneous administration in 7 day old rats for 6 month
with a 28 days recovery period.
Key facts
- NIH application ID
- 10953698
- Project number
- 271201700016I-P00005-759502000001-1
- Recipient
- IIT RESEARCH INSTITUTE
- Principal Investigator
- THOMAS HORN
- Activity code
- N01
- Funding institute
- NIH
- Fiscal year
- 2023
- Award amount
- $201,709
- Award type
- —
- Project period
- 2020-09-16 → 2024-07-08